glp 1 clinical studies The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine GLP-1-based therapies for diabetes, obesity

Results from the OUTSTAND-1 trial showed Hengrui/Kailera's HRS-7535 (KAI-7535) cut HbA1c by a highest placebo-adjusted 1.62% at 32 weeks, based on the treatment efficacy estimand.

What comes first

Stanford Medicine psychiatrist Anna Lembke unpacks the potential of FDA-approved weight-reducing GLP-1 drugs like Ozempic as tools in treating addiction.

Can you eat ice cream on Wegovy

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

GLP-1 semaglutide shows improved liver scarring in advanced MASH, early cirrhosis, offering a potential new treatment option in a large global trial study.